Loading...
Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation
PURPOSE: Both epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and chemotherapy are widely applied for the treatment of advanced non-small-cell lung cancer (NSCLC) with EGFR mutations, and the combination of EGFR-TKIs and chemotherapy has been used for advanced NSCLC patients;...
Na minha lista:
| Udgivet i: | Biologics |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6280904/ https://ncbi.nlm.nih.gov/pubmed/30555222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S169305 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|